Australia’s CSL has already bagged orders worth $180 million from US govt.
Jubilant has signed similar drug discovery services deals with AstraZeneca, Eli Lilly, Amgen, Orion and Bio Leap over the last 18 months.
India’s leading generic drug maker Dr Reddy’s Laboratories Ltd has announced its plans to hire 1,300 employees in various positions this year, despite recessionary trends that threatens to impact across the industries including pharma.
Trial registration is now mandatory before the enrollment of the first patient
India is, currently, the second largest foreign direct investor in UK.
Pfizer adds violation of a second patent on Lyrica in its case against Sun
Priligy (dapoxetine) is the first-ever oral pill approved to treat premature ejaculation
Indian contract manufacturing services provider Kemwell is building a new biopharmaceutical manufacturing plant in Bangalore, with technical assistance from the Germany-based Boehringer Ingelheim.
Indian vaccine makers including Bharat Biotech and Shantha Biotechnics see a bigger opportunity as the World Health Organisation (WHO) recommended that oral rotavirus vaccines be included in all national immunisation programmes.